Thirteen potential blockbuster drugs to watch in 2024
Drug Discovery World
JANUARY 9, 2024
However, government initiatives to contain healthcare costs, the sustained high cost of capital and global geopolitical disputes are negatively impacting investor appetites for the sector. The therapy has shown positive results in Phase III trials in both breast and lung cancer.
Let's personalize your content